A rheumatoid arthritis drug developed by Genentech proved to be effective in benefitting patients who have Covid-19-associated pneumonia, according to new late-stage clinical trial data.
https://www.pharmalive.com/wp-content/uploads/2020/09/Genentech-Drug-Benefits-Patients-with-COVID-19-Associated-Pneumonia-Study-Shows-BioSpace-9-18-20.jpeg350625Andrew Humphreyshttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngAndrew Humphreys2020-09-18 11:36:542020-09-18 15:12:20Genentech Drug Benefits Patients with Covid-19-Associated Pneumonia, Study Shows